Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA5271515
Chembl Id: CHEMBL5271515
Max Phase: Preclinical
Molecular Formula: C34H41ClN6O5S
Molecular Weight: 681.26
Associated Items:
ID: ALA5271515
Chembl Id: CHEMBL5271515
Max Phase: Preclinical
Molecular Formula: C34H41ClN6O5S
Molecular Weight: 681.26
Associated Items:
Canonical SMILES: C=C[C@]1(C)C[C@@H](OC(=O)CSc2nc(N)nc3c2ncn3C(=O)Nc2ccccc2Cl)[C@@]2(C)C3C(=O)CC[C@@]3(CC[C@H]2C)[C@@H](C)[C@@H]1O
Standard InChI: InChI=1S/C34H41ClN6O5S/c1-6-32(4)15-23(33(5)18(2)11-13-34(19(3)27(32)44)14-12-22(42)26(33)34)46-24(43)16-47-29-25-28(39-30(36)40-29)41(17-37-25)31(45)38-21-10-8-7-9-20(21)35/h6-10,17-19,23,26-27,44H,1,11-16H2,2-5H3,(H,38,45)(H2,36,39,40)/t18-,19+,23-,26?,27+,32-,33+,34+/m1/s1
Standard InChI Key: KREXARSYCRACDF-JATDXGTRSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 681.26 | Molecular Weight (Monoisotopic): 680.2548 | AlogP: 6.14 | #Rotatable Bonds: 6 |
Polar Surface Area: 162.32 | Molecular Species: NEUTRAL | HBA: 11 | HBD: 3 |
#RO5 Violations: 3 | HBA (Lipinski): 11 | HBD (Lipinski): 4 | #RO5 Violations (Lipinski): 3 |
CX Acidic pKa: 13.60 | CX Basic pKa: 1.51 | CX LogP: 5.41 | CX LogD: 5.41 |
Aromatic Rings: 3 | Heavy Atoms: 47 | QED Weighted: 0.12 | Np Likeness Score: 0.44 |
1. Yong C, Yu J, Wu C, Zhang X, Li Y, Xie C, He X, Liu D, Wang Z, Lai P, Zhang Y.. (2023) Design, Synthesis, and Biological Activity of Thioguanine-Modified Pleuromutilin Derivatives., 14 (6): [PMID:37312858] [10.1021/acsmedchemlett.3c00004] |
Source(1):